DSCM Insider Trading
DSCM | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at DSCM provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2011-05-11 01:15 | 2011-03-24 | Steeb James Orville | Officer - Pres & CEO, Salu Beauty, Inc. | SELL | $3.80 | 160,989 | $611,758 | 91,178 | -63.8% |
| 2011-03-30 00:33 | 2011-03-25 | McNeill Kathleen McKey | Officer - VP, Beauty | SELL | $3.90 | 20,000 | $78,000 | 94,076 | -17.5% |
| 2011-03-30 00:32 | 2011-03-25 | Lonczak David Lawrence | Officer - VP, Chief Marketing Officer | OPT+S | $3.90 | 127,142 | $495,854 | 144,478 | 0.0% |
| 2010-09-03 00:45 | 2010-08-31 | Friang Luke Thomas | Officer - VP, Chief Information Officer | SELL | $1.53 | 22,912 | $35,081 | 138,722 | -14.2% |
| 2010-08-14 00:30 | 2010-08-11 | Bennet Richard Wilson III | Director | BUY | $2.00 | 10,000 | $20,000 | 40,000 | +33.3% |
| 2010-08-12 23:50 | 2010-08-10 | Axelsson Jon Clarence | Officer - VP, Operations | BUY | $2.10 | 1,000 | $2,100 | 81,104 | +1.2% |
| 2010-08-12 00:03 | 2010-08-09 | Friang Luke Thomas | Officer - VP, Chief Information Officer | BUY | $2.10 | 4,000 | $8,400 | 161,634 | +2.5% |
| 2010-08-11 00:31 | 2010-08-06 | Wright Tracy Lynn | Officer - VP, Chief Finance Officer | BUY | $2.08 | 5,000 | $10,400 | 128,336 | +4.1% |
| 2010-08-11 00:30 | 2010-08-06 | Morikubo Yukio | Officer - VP, Strategy, Gen Couns & Sec | BUY | $2.08 | 6,500 | $13,520 | 150,808 | +4.5% |
| 2010-08-09 19:29 | 2010-08-06 | LEPORE DAWN G | Director, Officer - CEO, Pres + Chairman of Board | BUY | $2.09 | 10,000 | $20,865 | 1,154,656 | +0.9% |
| 2010-07-01 01:17 | 2010-06-28 | Johnston Julie Anne | Officer - VP, OTC Merchandising | OPT+S | $3.50 | 40,570 | $141,849 | 86,760 | 0.0% |
| 2010-06-30 01:23 | 2010-06-25 | Kelly Ronald Eugene | Officer - VP, Customer & Pharmacy Ops | OPT+S | $3.45 | 30,106 | $103,896 | 87,175 | 0.0% |
| 2010-06-24 01:08 | 2010-06-21 | Pavlovsky Stan | Officer - VP, Vision Direct | SELL | $3.45 | 23,892 | $82,427 | 67,999 | -26.0% |
| 2010-06-16 00:55 | 2010-06-11 | Wright Tracy Lynn | Officer - VP, Chief Finance Officer | SELL | $3.43 | 523 | $1,795 | 123,336 | -0.4% |
| 2010-06-16 00:54 | 2010-06-11 | Potter Robert Presley | Officer - VP, Chief Accounting Officer | SELL | $3.43 | 494 | $1,695 | 117,836 | -0.4% |
| 2010-06-16 00:54 | 2010-06-11 | Pavlovsky Stan | Officer - VP, Vision Direct | SELL | $3.43 | 494 | $1,695 | 91,891 | -0.5% |
| 2010-06-16 00:54 | 2010-06-11 | Morikubo Yukio | Officer - VP, Strategy, Gen Couns & Sec | SELL | $3.43 | 659 | $2,261 | 144,308 | -0.5% |
| 2010-06-16 00:53 | 2010-06-11 | McNeill Kathleen McKey | Officer - VP, Beauty | SELL | $3.43 | 408 | $1,400 | 118,439 | -0.3% |
| 2010-06-16 00:53 | 2010-06-11 | Lonczak David Lawrence | Officer - VP, Chief Marketing Officer | SELL | $3.43 | 567 | $1,946 | 149,990 | -0.4% |
| 2010-06-16 00:52 | 2010-06-11 | LEPORE DAWN G | Director, Officer - CEO, Pres + Chairman of Board | SELL | $3.43 | 1,780 | $6,108 | 1,144,656 | -0.2% |
| 2010-06-16 00:52 | 2010-06-11 | Kelly Ronald Eugene | Officer - VP, Customer & Pharmacy Ops | SELL | $3.43 | 428 | $1,469 | 112,138 | -0.4% |
| 2010-06-16 00:51 | 2010-06-11 | Johnston Julie Anne | Officer - VP, OTC Merchandising | SELL | $3.43 | 408 | $1,400 | 118,616 | -0.3% |
| 2010-06-16 00:51 | 2010-06-11 | Hargadon Robert Bernard | Officer - VP, Human Resources | SELL | $3.43 | 551 | $1,891 | 130,055 | -0.4% |
| 2010-06-16 00:51 | 2010-06-11 | Friang Luke Thomas | Officer - VP, Chief Information Officer | SELL | $3.43 | 420 | $1,441 | 157,634 | -0.3% |
| 2010-06-16 00:50 | 2010-06-11 | Axelsson Jon Clarence | Officer - VP, Operations | SELL | $3.43 | 1,004 | $3,445 | 80,104 | -1.2% |
| 2010-05-15 00:36 | 2010-05-12 | Kelly Ronald Eugene | Officer - VP, Customer & Pharmacy Ops | SELL | $3.65 | 6,893 | $25,159 | 112,566 | -5.8% |
| 2010-04-09 00:51 | 2010-04-03 | Wright Tracy Lynn | Officer - VP, Chief Finance Officer | SELL | $3.79 | 4,840 | $18,358 | 123,859 | -3.8% |
| 2010-04-09 00:51 | 2010-04-06 | Potter Robert Presley | Officer - VP, Chief Accounting Officer | SELL | $3.79 | 4,840 | $18,358 | 118,330 | -3.9% |
| 2010-04-09 00:50 | 2010-04-06 | Pavlovsky Stan | Officer - VP, Vision Direct | SELL | $3.79 | 3,053 | $11,580 | 92,385 | -3.2% |
| 2010-04-09 00:50 | 2010-04-06 | Morikubo Yukio | Officer - VP, Strategy, Gen Couns & Sec | SELL | $3.79 | 5,848 | $22,181 | 144,967 | -3.9% |
| 2010-04-09 00:49 | 2010-04-06 | McNeill Kathleen McKey | Officer - VP, Beauty | SELL | $3.79 | 4,071 | $15,441 | 118,847 | -3.3% |
| 2010-04-09 00:48 | 2010-04-06 | Lonczak David Lawrence | Officer - VP, Chief Marketing Officer | SELL | $3.79 | 5,088 | $19,298 | 150,557 | -3.3% |
| 2010-04-09 00:48 | 2010-04-06 | LEPORE DAWN G | Director, Officer - CEO, Pres + Chairman of Board | SELL | $3.79 | 63,263 | $239,950 | 1,146,436 | -5.2% |
| 2010-04-09 00:47 | 2010-04-06 | Kelly Ronald Eugene | Officer - VP, Customer & Pharmacy Ops | SELL | $3.79 | 4,071 | $15,441 | 119,459 | -3.3% |
| 2010-04-09 00:46 | 2010-04-06 | Johnston Julie Anne | Officer - VP, OTC Merchandising | SELL | $3.79 | 4,071 | $15,441 | 119,024 | -3.3% |
| 2010-04-09 00:46 | 2010-04-06 | Hargadon Robert Bernard | Officer - VP, Human Resources | SELL | $3.79 | 4,760 | $18,054 | 130,606 | -3.5% |
| 2010-04-09 00:45 | 2010-04-06 | Axelsson Jon Clarence | Officer - VP, Operations | SELL | $3.79 | 2,447 | $9,281 | 81,108 | -2.9% |
| 2009-12-30 22:25 | 2009-12-29 | KPCB VIII ASSOCIATES LP | 10% owner | SELL | $3.06 | 532,532 | $1,629,548 | 528,488 | -50.2% |
| 2009-12-30 23:41 | 2009-12-29 | KLEINER PERKINS CAUFIELD & BYERS VIII LP | 10% owner | SELL | $3.06 | 503,374 | $1,540,324 | 9,123,655 | -5.2% |
| 2009-12-23 23:58 | 2009-12-21 | KPCB VIII ASSOCIATES LP | 10% owner | SELL | $3.06 | 532,532 | $1,629,548 | 557,646 | -48.8% |
| 2009-12-23 23:55 | 2009-12-21 | KLEINER PERKINS CAUFIELD & BYERS VIII LP | 10% owner | SELL | $3.06 | 503,374 | $1,540,324 | 9,627,029 | -5.0% |
| 2009-10-09 00:00 | 2009-10-06 | Wright Tracy Lynn | Officer - VP, Chief Finance Officer | SELL | $2.27 | 4,176 | $9,491 | 128,699 | -3.1% |
| 2009-10-09 00:00 | 2009-10-06 | Potter Robert Presley | Officer - VP, Chief Accounting Officer | SELL | $2.27 | 4,176 | $9,491 | 123,170 | -3.3% |
| 2009-10-09 00:00 | 2009-10-06 | Pavlovsky Stan | Officer - VP, Vision Direct | SELL | $2.27 | 3,132 | $7,118 | 95,438 | -3.2% |
| 2009-10-08 23:59 | 2009-10-06 | Morikubo Yukio | Officer - VP, Strategy, Gen Couns & Sec | SELL | $2.27 | 5,045 | $11,465 | 150,815 | -3.2% |
| 2009-10-08 23:59 | 2009-10-06 | McNeill Kathleen McKey | Officer - VP, Beauty | SELL | $2.27 | 4,176 | $9,490 | 122,918 | -3.3% |
| 2009-10-08 23:59 | 2009-10-06 | Lonczak David Lawrence | Officer - VP, Chief Marketing Officer | SELL | $2.27 | 5,219 | $11,860 | 155,645 | -3.2% |
| 2009-10-08 23:58 | 2009-10-06 | LEPORE DAWN G | Director, Officer - CEO, Pres + Chairman of Board | SELL | $2.27 | 84,048 | $191,016 | 1,209,699 | -6.5% |
| 2009-10-08 23:58 | 2009-10-06 | Kelly Ronald Eugene | Officer - VP, Customer & Pharmacy Ops | SELL | $2.27 | 4,176 | $9,491 | 123,530 | -3.3% |
| 2009-10-08 23:58 | 2009-10-06 | Johnston Julie Anne | Officer - VP, OTC Merchandising | SELL | $2.27 | 4,176 | $9,490 | 123,095 | -3.3% |
How to Interpret $DSCM Trades
Not every insider transaction in DSCM is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $DSCM shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for DSCM
Insider activity data for DSCM is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $DSCM, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.